Search

Author/Creator Crowe, Brenda

1. [P1–044]: SAFETY OF SOLANEZUMAB IN PHASE 3 STUDIES IN INDIVIDUALS WITH MILD ALZHEIMER's DISEASE DEMENTIA. (1st July 2017)

Authors:
Carlson, Christopher D.; Anglin, Greg; Case, Michael G.; Crowe, Brenda; Hake, Ann Marie; Khanna, Rashna; Kryzhanovskaya, Ludmila; Perahia, David; Sethuraman, Gopalan; Yaari, Roy; Dowsett, Sherie A.; Siemers, Eric R.
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 5
Page Start:
P251
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adaptation of the robust method to large distributions of reference values: program modifications and comparison of alternative computational methods. Issue 3 (4th May 2019)

Authors:
Beasley, Charles M.; Crowe, Brenda; Nilsson, Mary; Wu, Lieling; Tabbey, Rebeka; Hietpas, Ryan T.; Dean, Robert A.; Horn, Paul S.
Journal:
Journal of biopharmaceutical statistics
Issue:
Volume 29:Issue 3(2019)
Page Start:
516
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I). Issue 10381 (25th March 2023)

Authors:
Morand, Eric F; Vital, Edward M; Petri, Michelle; van Vollenhoven, Ronald; Wallace, Daniel J; Mosca, Marta; Furie, Richard A; Silk, Maria E; Dickson, Christina L; Meszaros, Gabriella; Jia, Bochao; Crowe, Brenda; de la Torre, Inmaculada; Dörner, Thomas
Journal:
Lancet
Issue:
Volume 401:Issue 10381(2023)
Page Start:
1001
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗